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ABSTRACT
Characterizing Interaction Between PASK and PBP1/ ATXN2
to Regulate Cell Growth and Proliferation
Nidhi Rajan Choksi
Department of Microbiology and Molecular Biology, BYU
Master of Science
Pbp1 is a component of glucose deprivation induced stress granules and is involved in Pbody-dependent granule assembly. We have recently shown that Pbp1 plays an important role in
the interplay between three sensory protein kinases in yeast: AMP-regulated kinase (Snf1 in
yeast), PAS kinase 1 (Psk1 in yeast), and the target of rapamycin complex 1 (TORC1), to
regulate glucose allocation during nutrient depletion. This signaling cascade occurs through the
SNF1-dependent phosphorylation and activation of Psk1, which phosphorylates and activates
poly(A)- binding protein binding protein 1 (Pbp1), which then inhibits TORC1 through
sequestration at stress granules. In this study we further characterized the regulation of Pbp1 by
PAS kinase through the characterization of the role of the Psk1 homolog (Psk2) in Pbp1
regulation, and the identification of functional Pbp1 binding partners. Human ataxin-2 (ATXN2)
is the homolog of yeast Pbp1 and has been shown to play an important role in the development
of several ataxias. In this study we have also provided the evidence that human ataxin-2 can
complement Pbp1 in yeast, and that human PAS kinase can phosphorylate human ataxin-2.
Further characterizing this interplay between PAS kinase and Pbp1/ATXN2 aid in understanding
pathways required for proper glucose allocation during nutrient depletion, including reducing
cell growth and proliferation when energy is low. In addition, it yields valuable insights into the
role of ataxin-2 in the development of devastating ataxias.

Keywords: nutrient sensing kinases, AMP regulated kinase (AMPK), PAS kinase (PSK or
PASK), Target of Rapamycin (TOR), Pbp1, Ataxin-2 (ATXN2)
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SPECIFIC AIMS
1. To determine whether the pathway between PAS kinase, Pbp1 and TORC1 is conserved in
yeast.
A) To determine whether the human homolog of Pbp1 can complement yeast Pbp1 in the
inhibition of TORC1.
B) To determine whether human PAS kinase can directly phosphorylate ataxin-2 using in
vitro kinase assays.
2. To further characterize the regulation of Pbp1 by PAS kinase in yeast.
A) Yeast has two homologs of PAS kinase, Psk1 and Psk2. The role of Psk2 in Pbp1
regulation will be explored through phenotypic assays.
B) To determine whether human PAS kinase 2 can directly phosphorylates Pbp1 using in
vitro kinase assays.
C) To characterize the PAS kinase-phosphorylation of Pbp1 through phosphosite mapping
and mutagenesis.
3. To define the function of Pbp1, and hence PAS kinase, through identifying the binding
partners of Pbp1 using yeast 2-hybrid method.
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1

INTRODUCTION
Eukaryotic cell proliferation is controlled by growth factors, hormones, and/or the

availability of nutrients. In the absence of a corresponding proliferation signal, cells may enter
into a specific, reduced growth and proliferation state, generally associated with increased
resistance to various environmental stresses. An essential element of biological adaptation to
changing environmental conditions is the use of sensory proteins that transduce various stimuli
into changes in the activity of downstream signaling pathways [1].
In the yeast Saccharomyces cerevisiae, cell growth and proliferation is regulated by the
availability of nutrients through nutrient sensing enzymes that sense and distribute nutrients
properly. Nutrient-sensing kinases maintain metabolic homeostasis by allocating cellular
resources in response to nutrient status. This allows organisms to adapt to the circumstances of
the environment, being able to switch between energy consumption pathways to storage
pathways. The ability to control multiple central metabolic pathways has made nutrient sensing
kinases the target of many therapeutic approaches [1, 2]. Three of these nutrient sensing kinases
are the AMP-regulated kinase (AMPK or Snf1), PAS kinase, and the target of rapamycin (TOR)
each playing a unique role in sensing and utilizing nutrients in the cell.
1.1

AMPK or Snf1
The AMP-activated protein kinase (AMPK) is a highly conserved kinase complex

composed of a catalytic (α) subunit and two regulatory (ß and ϒ) subunits [3]. AMPK is a highly
conserved sensor of cellular energy status that is activated under conditions of low intracellular
ATP. When energy status is compromised, the system activates catabolic pathways and switches
off protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation [4].
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AMPK was first known for its role in regulating fatty acid and cholesterol synthesis.
AMPK was discovered as an inhibitor of Acetyl-CoA carboxylase, the rate limiting enzyme in
long chain fatty acid synthesis [6]. It was later found that this inhibition occurred with low ATP
availability [7], with AMPK activated when the AMP to ATP ratio is high. AMP directly binds
to the AMPK complex and allosterically activates it [44]. AMPK responds to energy stress by
suppressing cell growth and biosynthetic processes, in part through its inhibition of the
rapamycin-sensitive mTOR (mTORC1) pathway in mammalian cells [43]. Recent studies
indicate that the AMPK system is also important in functions that go beyond the regulation of
energy homeostasis, such as the maintenance of cell polarity in epithelial cells [5].
Snf1 is a homologue of AMPK in Saccharomyces cerevisiae and is essential for
responses to glucose starvation as well as for other cellular processes. Snf1 functions similar to
AMPK in that it activates respiration, and decreases fatty acid biosynthesis in yeast [9]. The Snf1
complex acts primarily by inducing expression of genes required for catabolic pathways that
generate glucose, probably by triggering phosphorylation of transcription factors [8]. Snf1 kinase
activity allows for the expression of genes, including those required for respiration, normally
repressed when glucose is readily available. Thus, Snf1 mutates in yeast lose their ability to grow
on non-fermenting carbon sources such as sucrose [10]. In contrast to mammalian AMPK, Snf1
seems to be activated by a ligand other than AMP.
1.2

Target of Rapamycin (TOR)
TOR is a nutrient sensing kinase that is activated under nutrient rich conditions [22].

TOR can form two complexes, TORC1 and TORC2 [23]. TORC1 is sensitive to rapamycin. The
core components of TORC1 include tor1, tor2, Lst8 and Kog1 that control protein synthesis in
response to growth factors and nutrients [25, 27]. TORC2 is core components include rapamycin
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insensitive protein tor2, Sin1, PRR5, PRR5L and lst8. TORC2 regulates cell survival, cell cycle
progression, and metabolism by phosphorylating and activating other effector kinases. TORC2 is
also involved in actin organization during cell division [24].
TORC1 is activated during times of nutrient abundance, such as high amino acid
concentrations, high glucose availability or the presence of growth factors and activates
ribosomal translation. TORC1 can phosphorylate two proteins that modulate components of the
protein translation machinery. TORC1 phosphorylates S6 kinase (S6K). S6K in turn
phosphorylates ribosomal protein S6 and thus increases cell growth [28]. The second link
between TORC1 and protein synthesis is TORC1 can phosphorylate eukaryotic initiation factor
(eIF) 4E binding proteins (4E-BPs). When 4E-BP is phosphorylated it prevents the mechanism
of translation [50]. TORC1 can also upregulates lipid biosynthesis to allow for cell growth [51].
In summary TORC1 is activated in the presence of nutrient rich conditions and promotes cell
growth and proliferation via protein, ribosome and lipid biosynthesis.
TORC1 signaling upon heat stress is regulated by stress granules (SGs), which are
cytoplasmic foci formed under certain stresses [22]. Ectopic formation of SGs achieved by Pbp1
overexpression in unstressed cells sequesters TORC1 in this compartment, thereby blunting
TORC1 signaling [52]. Upon heat stress, a physiological SG-inducing condition, TORC1 is also
recruited to SGs, which delays reactivation of TORC1 signaling during recovery from heat
stress. Moreover, TORC1 reactivation is directed through SG disassembly, suggesting that SGs
act as a key determinant for TORC1 reactivation during recovery from heat stress [22].
Furthermore, this mechanism contributes to reduction of heat-induced mutations. Thus, TORC1
signaling is coupled to heat-induced SGs to protect cells from DNA damage [26].
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1.3

PAS kinase
PAS kinase is a recently discovered sensory protein kinase. PAS kinase is highly

conserved from yeast to man [11]. PAS kinase contains both a catalytic kinase domain and a
regulatory PAS domain. PAS domains are sensory domains that regulate protein activity by
binding small molecules or proteins [12, 13] while the kinase domain regulates other proteins
through phosphorylation. The PAS domain binds the kinase domain to inhibit its catalytic
activity [45]. PAS kinase has been shown to be involved in the regulation of glucose homeostasis
in both yeast and mice [14].
PAS kinase is important in the allocation of glucose in the cell. PAS kinase-deficient
mice (PASK-/-) have an increased metabolic rate and are resistant to weight gain, liver
triglyceride accumulation and insulin resistance; when placed on a high-fat diet [15]. There is no
significant difference between PAS kinase deficient mice and wild type in their food intake or
activity levels; instead PAS kinase deficient mice appear to be hyper-metabolic, with more
energy being released as heat [15]. Also, PAS kinase deficiency in mice appears to confer a
protective effect against the development of type II diabetes, and human mutations in PAS
kinase (hPASK) have been found that lead to development of maturity-onset diabetes in the
young (MODY) [49].
A psk1psk2 mutant yeast strain accumulates excess carbohydrate and shows a reduction
in glucans necessary for cell wall biosynthesis [46]. In addition, the cells have an impaired
ability to grow on galactose. PAS kinase is able to phosphorylate UDP-glucose
pyrophosphorylase (Ugp1) and glycogen synthase [14]. Ugp1 is the major producer of UDPglucose, which can be used for glycogen synthesis and cell wall synthesis [47]. When PAS
kinase phosphorylates Ugp1 it is believed to change its cellular location, from the cytoplasm to
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the cell periphery, which results in the donation of glucose to cell wall components at the
expense of glycogen formation [46]. Human PAS kinase was also found to phosphorylate
mammalian glycogen synthase and inhibit glycogen synthase activity [48].
In addition to its role in glycogen accumulation, PAS kinase has also been shown to
regulate respiration in yeast through the phosphorylation and inactivation of Cbf1 [49]. In this
large-scale study, 93 binding partners were identified for yeast PAS kinase 1 (Psk1), and four
were shown to be in vitro substrates of PAS kinase, namely Cbf1, Pbp1, Zds1 and Utr1. Cbf1 is
a transcription factor that regulates respiration as well as lipid and amino acid biosynthesis, and
is inhibited by Psk1-dependent phosphorylation. Pbp1, or Pab1p - binding protein, is activated
by PAS kinase [52]. It is known to function by regulating mRNA tail length, localizing to stress
granules, and inhibiting TORC1 through sequestration at these granuales [22]. Thus we see that
PAS kinase plays an important role in coordinating a metabolic response in yeast, mice and
humans.
TOR and PAS kinase proteins also define key signaling pathways that control cell
proliferation in response to growth factors and/or nutrients. In yeast, inactivation of PAS kinase
and/or TOR causes cells to arrest growth in early G1 and induces a program that is characteristic
of G0 cells [16]. Interestingly, PAS kinase was found to phosphorylates Cap-Associated Factor
20 (Caf20) which is a part of eukaryotic initiation factor 4E (eIF4E) complex and negatively
regulates translation by blocking assembly of the translation initiation complex [17, 18]. PAS
kinase can also phosphorylate Tif1, which is the yeast eukaryotic translation initiation factor 1A
(eIF1A) [19]. eIF1A transfers Met-tRNA to the 40S preinitiation complex [20]. These data
indicate that PAS kinase may, like TOR, regulate protein synthesis through phosphorylation of
downstream effectors, but the significance of its effect on translation has not been defined [21].
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1.4

Crosstalk between nutrient sensing enzymes
PAS kinase is activated by Metabolic and Cell Integrity Stress. Interestingly, Snf1 was

found to be required for activation of PAS kinase under stressing conditions [49], PAS kinase
and Snf1 actives under glucose deprivation [17]. Another interesting observation was that the
yeast orthologsPsk1 and Psk2 play a different role in response to the two stimuli, with Psk1
having the major role in response to metabolic stress [17].
In yeast the interplay between three sensory protein kinases, AMP-regulated kinase
(AMPK, or Snf1 in yeast), PAS kinase 1 (Psk1 in yeast), and the target of rapamycin complex 1
(TORC1), plays an important role to regulated cell growth and proliferation when energy is low.
This signaling cascade occurs through the SNF1-dependent phosphorylation and activation of
Psk1, which phosphorylates and activates Pab1p - binding protein 1 (Pbp1), which then inhibits
TORC1 through sequestration at stress granules [52].
1.5

Pbp1
An important part of the cellular response to stress or environmental stimuli is the

modulation of cytoplasmic mRNA translation and degradation. One aspect of this process in
eukaryotic cells is the remodeling of translating mRNAs into non-translating mRNPs that
accumulate in cytoplasmic foci known as stress granules and P-bodies to allow for storage and
decay of mRNA [29]. Stress granules arise when translation initiation is strongly inhibited, such
as during different environmental stresses or drug-induced translational repression, and contain
translationally inactive mRNA and translation initiation factors [30]. Understanding the
composition and formation of these two granules will provide insight into how mRNA fate is
controlled during stress and during normal growth. While the function of these large aggregates
is not entirely known, their composition provides some clues as to their roles.
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Recent studies in both yeast and mammalian cells implicate a role for Pbp1 (Pab1binding protein) and Ataxin-2 (mammalian homolog of Ppb1), in the assembly of stress granules.
Deletion of Pbp1 in yeast or siRNA knockdown of Ataxin-2 in mammalian cells leads to
significant decreases in stress granule formation under glucose deprivation or arsenite treatment,
respectively [31, 32]. These results suggest that Pbp1 and its interacting proteins may localize to
and play roles in stress granule assembly. Pbp1 interacts with some interesting proteins with
possible roles in the control of cytoplasmic mRNA function. Pbp1 was identified by an
interaction with the C-terminal domain of Pab1, and was found to exist with both the translating
and nontranslating pools of mRNA [33, 34]. Pbp1 also interacts with the Pbp4 and Lsm12
proteins, and these three proteins all associate with the translation machinery [35, 36]. Moreover,
a physical interaction between Pbp1 and Dhh has been demonstrated by a protein-fragment
complementation assay, as well as a physical interaction between Dhh1 and Lsm12 [37].
It has been shown that overexpression of Pbp1, a poly(A)-binding protein (Pab1)-binding
protein I and a component of stress granules (SGs) [38], downregulates TORC1 by inducing SG
formation, where TORC1 is sequestered [22]. Since, Pbp1 is activated by PAS kinase, and PAS
kinase phosphorylates Pbp1, Pbp1 plays a critical role in the interplay between three sensory
protein kinases in yeast to regulate glucose allocation during nutrient depletion. Although Pbp1
signaling is elevated by various stresses in yeast, the underlying mechanisms remain elusive.
1.6

ATXN2
Human ataxin-2 (ATXN2) is a homolog of yeast Pbp1. This gene is a product of the

spinocerebellar ataxia type 2 gene (SCA2)[39, 40, 41]. Spinocerebellar ataxia type 2 (SCA2) is a
member of the growing group of familial neurodegenerative diseases characterized by unstable
CAG repeats which are expanded in patients. The trinucleotide repeat encodes a polyglutamine
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stretch in the N-terminal region of ATXN2. This stretch is expanded in SCA2 patients and
confers an increased propensity towards functional defects leading to ataxia and ultimately death
[42]. The mechanism, however, by which the expansion triggers neuronal cell death, has
remained unclear [53].
The causes of amyotrophic lateral sclerosis (ALS), a devastating human
neurodegenerative disease, are poorly understood, although the protein TDP-43 has been
suggested to have a critical role in disease pathogenesis. Scientists have shown that ataxin-2
(ATXN2), a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2, is a potent
modifier of TDP-43 toxicity in animal and cellular models [54]. ATXN2 and TDP-43 associate
in a complex that depends on RNA. In spinal cord neurons of ALS patients, ATXN2 is
abnormally localized; likewise, TDP-43 shows mislocalization in spinocerebellar ataxia type 2.

ATXN2

Pbp1

Figure 1-1: Domain architecture of human ATXN2 and its yeast homolog Pbp1.

In summary, mutations in ATXN2 are strongly associated with ataxias, yet little is known
about the function of ATXN2. Thus, as ATXN2 functions similar to Pbp1, our studies may help
us understand why human mutations in this protein lead to ataxia. In support of conserved roles
for Pbp1 and ATXN2, our study shows that ATXN2 can actually complement Pbp1 phenotype in
9

yeast cells. This provides an incredibly powerful tool to study human mutations using yeast as a
model organism.
The proposed study aims to investigate another level of cross talk between PAS kinase
and Pbp1/ATXN2. Preliminary data suggests that PAS kinase phosphorylates and activates
Pbp1. This study will further our understanding on how PAS kinase interacts with Pbp1. It will
also provide an understanding of how Pbp1 and ATXN2 function, emphasizing the effects of
PAS kinase on Pbp1 and ATXN2 function.
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2

BACKGROUND AND SIGNIFICANCE
In yeast, Psk1 is activated in a SNF1-dependent manner in response to energy/nutrient

deprivation [17]. Phosphorylation activates PAS kinase by interfering with inhibitory binding of
the PAS domain. Once activated, Psk1 phosphorylates Pbp1 [52], which sequester TORC1 to
stress granules, inhibiting cell growth [22].

Figure 2-1: A model for the cross-talk between the nutrient-sensing kinases SNF1, TORC1, and
Psk1.
The fact that overexpression of Pbp1 leads to apparent growth inhibition by inhibition of
TORC1, makes it an efficient target of anti-cancer therapies. Therefore identifying the molecular
mechanism behind Pbp1 activation and its function will increase our understanding of glucose
regulation, and cell growth and proliferation.
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Human ATXN2 is a homolog of yeast Pbp1. The molecular functions of ATXN2 have
not been understood to date. However, some evidence provided by studying ATXN2 homologs
from yeast, C. elegans, and D. melanogaster, indicates that they may be involved in RNAprocessing pathways [53, 54, 55]. In this study, we will also further characterize the role of
ATXN2. In addition, we will investigate whether PAS kinase also phosphorylates ATXN2. This
study will increase our understanding of the nutrient sensing kinase PAS kinase, and its role in
regulating basic cellular metabolism. Therefore, discovering the molecular mechanisms behind
PAS kinase function is essential in that it will not only increase our understanding for the
treatment of metabolic disease, but contribute to our basic understanding of metabolic regulation
in cells. In addition, the proposed research project could help us understood the molecular
mechanisms behind neuronal death reported in ATXN2-associated ataxia. If PAS kinase
regulates ATXN2, it may be a therapeutic target in the treatment of ataxias, a disease with few
successful treatment options.
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3
3.1

MATERIALS AND METHODS
Growth assays
Lists of strains, plasmids, and primers used in this study are provided in APPENDIX A.

For plasmid construction, standard PCR-based cloning methods were used. All restriction
enzymes were purchased from New England BioLabs (Ipswich, MA).
Yeast two-hybrid bait plasmid was made by PCR amplification of Pbp1 and subsequent
cloning into the EcoRI/SalI sites of pGBD-C1 yeast two-hybrid Gal4 bait vector (pJG424)[57]
(pJG1386 [JG2916/3163]). Yeast two-hybrid libraries are described in an earlier work [49].
Yeast two-hybrid Gold cells (Clontech, Mountain View, CA) were used to transform in bait and
prey plasmids for interaction studies.
For serial dilution growth assays, spot-dilutions were performed by growing yeast in
overnight liquid culture, serially diluted 1:10 in water and spotted on selective plates as well as
control plates. Plates were incubated at 30°C for 7–10 d until colonies were apparent.
3.2

Histidine- and Myc-tagged protein purification
Yeast harboring plasmids for 6X histidine (HIS) or Myc-tagged protein expression were

grown in either SD-Ura media overnight, diluted 1:100-fold into 100 or 250 ml of SD-Ura, and
grown for 10–12 h, pelleted, and resuspended in 500 ml of SGal-Ura for 36 h to induce
expression under the GAL1-10 promoter. Yeast were pelleted and flash frozen at -80ºC. Yeast
were then resuspended in lysis buffer for HIS-tag purification (50 mM 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid [HEPES], 300 mM NaCl, 20 mM imidazole, 10 mM KCl, 1
mM β-mercaptoethanol, and complete Protease Inhibitor Cocktail Tablet [Roche], pH 7.8, with
phosphatase inhibitors, 50 mMNaF, and glycerophosphate when necessary) or for Myc
purification (20 mM HEPES, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 50 mM NaCl, 10%
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glycerol,1 mM β-mercaptoethanol, complete Protease Inhibitor Cocktail Tablet, pH 7.4, with
phosphatase inhibitors when necessary). Resuspended cultures were lysed using the
Microfluidics M-110P homogenizer (Microfluidics, Westwood, MA) for 500-ml cultures or bead
blasted for 1 min, followed by 1 min on ice repeated three times using 0.2-mm glass beads for
small cultures (100 to 250 ml). Cell debris were then pelleted at 12,000 rpm for 20–30 min.
Supernates were transferred to new tubes and incubated with either 200 μl of nickelnitrilotriacetic acid (Ni-NTA, Qiagen, Valencia, CA) agarose beads for 500-ml HIS purification,
or 5–10 μl of Myc-conjugated magnetic beads (Cell Signaling, Danvers, MA) for Myc
purification, for 2–3 h at 4°C. For HIS-epitope purification, beads were washed twice with 15 ml
of lysis buffer and then transferred to a polypropylene column and washed with 30–50 ml of
lysis buffer. For Myc-protein purification, beads were separated using magnetic force and
washed four times with 500 μl of lysis. HIS-tagged proteins were eluted three times with 0.3 ml
of Elution Buffer (lysis buffer containing 270 mM imidazole, 10Mm KCl and 50mMNaCl pH
7.8). Beads containing Myc-tagged proteins were used directly for in vitro kinase assays without
eluting.
3.3

Pbp1 PAS kinase in vitro kinase assay
Psk1 (pJG858), Psk2 (pJG173), and Psk2-KD (pJG174) was HIS purified from psk1psk2

yeast (JGY4). Myc-tagged Pbp1 was purified from psk1psk2 (JGY4) yeast. Purified
∆N419Pbp1-Myc–tagged proteins were assayed for PAS kinase–dependent phosphorylation by
incubating purified protein in 30 μl of reaction buffer containing 1× PAS kinase buffer (0.4 M
HEPES, 0.1 M KCl, 5 mM MgCl2, pH 7.0), 0.2 mM ATP, 32P-ATP [5 μCi; MP Biomedicals,
Santa Ana, CA]) in the presence or absence of HIS purified full-length Psk2 or Psk1, or kinasedead Psk2-K870R. Kinase assays were started with the addition of PAS kinase and stopped with
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SDS–PAGE sample buffer. Reactions were incubated for 12 min at 30°C, seperated on SDSPAGE gels, stained with Coomassie Blue and dried. The protein gels were then incubated on
film overnight, and visualized the next day. By developing film using kinase dead PAS kinase 2
to check for auto-phosphorylation of Pbp1.
3.4

ATXN2 hPAS kinase in vitro kinase assay
∆N544ATXN2 was purified from psk1psk2 yeast (JGY4) using HIS-tag purification.

Purified ATXN2 protein was assayed for human PAS kinase–dependent phosphorylation by
incubating purified ∆N544ATXN2 protein in 30μl of reaction buffer (0.4 M HEPES, 0.1 M KCl,
5 mM MgCl2, pH 7.0), 1mM ATP, 32P-ATP [5 μCi; MP Biomedicals, Santa Ana, CA] with or
without purified human PAS kinase. Samples were inculcated at 30 min at 30°C. Kinase assays
were started with the addition of human PAS kinase and stopped with SDS–PAGE sample
buffer. Reactions were seperated on 10% SDS polyacrylamide gels and proteins were stained
with Coommassie Blue and dried. The protein gels were then exposed to film for 6 hours and
visualized on film. GAPDH was used to check non-specific phosphorylation of human PAS
kinase, and substrate or kinase alone were used to check for auto-phosphorylation.
3.5

Pbp1 phosphosite mutants
Three sets of multiple site-directed mutations were incorporated in Pbp1 using the

StrategeneQuikChange kit and cloned into a HIS expression vector under the GAL1-10 promoter
by PCR amplification of Pbp1 with primers JG2916/2917 and cloning into the EcoRI/XhoI sites
of pJG859. Plasmids and mutations (designated by amino acid change) are shown in Table 3-1.
All mutations were confirmed by sequencing and the encoded proteins were subjected to in vivo
kinase assays.
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Table 3-1: Phosphosite mutants of Pbp1
Plasmid

Mutation in amino acid

pJG1561

S106A, T193A, S436A, S479A, T708A, T718A

pJG1562

S106A, T193A, T355A, S436A, S479A, T708A

pJG1563

S106A, T215A, T355A, S436A, S479A, T708A, T718A

3.6

In vivo kinase assay
HIS-tagged Pbp1 (pJG1560) was expressed in WT yeast (JGY1) overexpressing full-

length Psk1 on a plasmid (pJG9) or in psk1psk2 yeast (JGY4) containing an empty vector
(pJG124). Phospho-site mutants of Pbp1 (pJG1561, pJG1562 and pJG1563) were expressed in
JGY1 (WT) overexpressing full-length Psk1 on a plasmid (pJG9). Proteins were grown in
duplicate in SD-Ura-Trp overnight, induced with SGal-Ura-Trp for 36 h, and purified on NiNTA as described above. Eluates were run on 10% SDS–PAGE, transferred to nitrocellulose
membrane, and incubated overnight with nonspecific PhosphoThreonine antibody (Cell
Signaling Technology). Blots were imaged, stripped by incubating in striping reagent (6.75mM
Tris, 2% SDS, and 10mM β-mercaptoethanol) for 30 minutes at 50ºC followed by 10x wash in
TBST buffer for 5 minutes, and then incubated overnight with PhosphoSerine (Q5; Qiagen)
antibody. Total Pbp1 was assessed by stripping the membrane once more, incubating overnight
with anti-HIS antibody (Cell Signaling Technology), and imaging.
3.7

Yeast 2-Hybrid Screening
Yeast 2-hybrid system were used to look for a protein-protein interaction. The yeast 2-

hybrid modifies the transcription factor for the Gal4 promoter. The transcription factor has a
DNA binding domain and an activation domain that recruits RNA polymerase. The yeast 216

hybrid system cleaves the activation and binding domain and fuses them with a protein that will
either serve as the bait (bound to binding domain) or prey (bound to activation domain). When
the two proteins interact in the cell it now allows for the Gal4 transcription factor binding
domain and activation domain to become close enough to each other to recruit RNA polymerase
to the promoter region and allow for expression of the reporter genes [63]. Pbp1 was cloned into
binding domain (pJG1386) and the library was previously cloned into activation domain [49]
(pJG428, pJG429, JGY1079 and JGY1098). Yeast containing both plasmids were selectively
grown on SD-Leu-Trp. Colonies were then streaked onto selective media SD-Leu-Trp-His-Ade,
where growth indicates a protein-protein interaction due to expression of reporter genes.
Yeast 2-Hybrid screening by mating
For cDNA library screens, α haploid yeast harboring a cDNA Y2H prey library (JGY1074
and JGY1098) [49] was mated to a haploid yeast harboring ΔN419Pbp1 Bait (JGY1383) in 2X
YPAD for 24 hours at @ 30°C. Yeast cells where then pelleted and diluted using 10mL of SDLeu-Trp media followed by plating 100uL on 100 SD-Leu-Trp-His-Ade plates.
Yeast 2-Hybrid screening by transformation
For genomic library screens, the Y2HGold (Clontech) strain bearing ΔN419Pbp1 Bait
(JGY1383) was transformed with genomic libraries (pJG428, or pJG429) obtained from David
Stillman, University of Utah [57]. Yeast cells where then pelleted and diluted using 10mL of SDLeu-Trp media followed by plating 100uL on 100 SD-Leu-Trp-His-Ade plates.
3.8

Colony check and Dependency assay
Colonies that arose on Y2H selection plates (SD-Leu-Trp-His-Ade) were again patched on

SD-Leu-Trp-His-Ade plates for validation. The library plasmid inserts were then identified by
colony PCR with subsequent sequencing (Brigham Young University DNA Sequencing Center)
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and National Center for Biotechnology Information (NCBI) BLAST [64] analysis (an
unambiguous hit with e-value of ≥10e−45). For verification and elimination of false positives,
library plasmids were purified from yeast [58], amplified in Escherichia coli (GenElute Plasmid
Mini-prep Kit, Sigma-Aldrich, St. Louis, MO), and transformed into Clontech Matchmaker Gold
yeast with either the Pbp1 bait plasmid (pJG1386) or the empty bait plasmid (pJG424). Colonies
arising on the SD-Leu-Trp transformation plates were then streaked onto SD-Leu-Trp-His-Ade
in duplicate and allowed to grow for 3–5 d to test for Pbp1 dependence. The strength of growth
was determined by comparing growth of yeast on SD-Leu-Trp-His-Ade plates, which is an
indication of the interaction strength (S, strong; M, medium; W, weak).
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4
4.1

RESULTS
Complementation of Pbp1 phenotype by ATXN2 in yeast
We previously provided evidence for the PAS kinase-dependent phosphorylation of Pbp1

[52], which then sequesters TORC1 into stress granules, inhibiting growth and proliferation [22].
ATXN2 is the human homologue of yeast Pbp1 [26] and both ATXN2 and Pbp1 have conserved
Lsm, LsmAD and self-interacting domains [60] (See Figure 1-1). The self interacting region of
Pbp1 gets phosphorylated by PAS kinase [52]. To test whether ATXN2 could complement Pbp1
function in its ability to reduce cell growth and proliferation under stress by sequestering TORC1
in to stress granules, three truncation of ATXN2 (∆N379ATXN2, ∆N544ATXN2 and
∆N700ATXN2) (Figure 4-1) were cloned into a HIS-tagged yeast expression vector, transformed
into pbp1 yeast and grown on selective media containing caffeine to check for a TORC1
phenotype. ∆N544ATXN2 overexpression in cells rendered the cells sensitive TORC1 inhibitor,
caffeine [27], suggesting that the ATXN2 overexpression inhibits TORC1 activity (Figure 4-2).
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Figure 4-1:ATXN2 truncations used to screen for interaction with PAS kinase.

pPbp1, pbp1
pEV, pbp1
aa700-1312ATXN2, pbp1
aa554-1312ATXN2, pbp1
aa379-1312ATXN2, pbp1
SGal-Ura+1.87mM Caffeine

SD-Ura

Figure 4-2: Evidence of the inhibition of TORC1 by human ∆N554ATXN2 in yeast. ATXN2,
like Pbp1, causes sensitivity to caffeine when overexpressed, most likely due to the inhibition of
TORC1 [52]. Pbp1 deficient yeast (JYG1122) were transformed with ∆N700ATXN2
(pJG1361), ∆N554ATXN2 (pJG1360), ∆N379ATXN2 (pJG1359), pPbp1 (pJG925), or empty
vector (pJG859) grown in SD-Ura, serially diluted 1:10, and spotted on SGal-Ura + 1.87 mM
caffeine plates, and on a control SD-Ura plate. Plates were incubated at 30°C for 7–10 d until
colonies were apparent.
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To determine whether the phosphorylation of ATXN2 by PAS kinase can regulate the
inhibition of TORC1, we transformed wild type and psk1psk2 yeast with ∆N554ATXN2 or Pbp1
and checked the effect of growth on media containing caffeine [22, 52]. Overexpression of
∆N554ATXN2 driven by the Gal promoter used in this study did induce significant growth
inhibition in wild-type cells when compared to psk1psk2 cells. These results suggest that PAS
kinase may activate ATXN2 under stress conditions, which may then sequester TORC1 in stress
granules and reduce cell growth and proliferation similar to Pbp1.

aa554-1312ATXN2, WT
pPbp1, WT
pEV, WT

aa554-1312ATXN2,psk1psk2
pPbp1, psk1psk2
pEV, psk1psk2
SGal-Ura+1.87mM

SD-Ura

Figure 4-3: Evidence for the activation of Pbp1 and ATXN2 by PAS kinase. Psk1Psk2
deficiency decreased caffeine toxicity due to ATXN2 and Pbp1 overexpression. Wild-type
(JGY299) or psk1psk2 yeast (JGY1161) was transformed with an empty vector (EV, pJG859), a
plasmid overexpressing Pbp1 (pJG925), or plasmid overexpressing ∆N554ATXN2 grown in SDUra, serially diluted 1:10, and spotted on SGal-Ura + 1.87 mM caffeine plates, and on a control
SD-Ura plate. Plates were incubated at 30°C for 7–10 d until colonies were apparent.
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4.2

Evidence for direct phosphorylation of human ATXN2 by human PAS kinase
The mutations in ATXN2 are found strongly associated with human ataxias [39] and we

have recently shown that overexpression of ATXN2 in the presence of PAS kinase can inhibit
growth and proliferation in yeast (Figure 4-3), in this aim we checked whether human PAS
kinase can directly phosphoryalte human ATXN2. HIS purified ∆N554ATXN2 was incubated
with human PAS kinase in the presence of radioactive ATP and the phosphorylation of ATXN2
was assayed by autoradiography. Human PAS kinase dependent phosphorylation of ATXN2 was
seen on the in vitro kinase assay (Figure 4-4), which suggest that hPASK can phosphorylates
human ATXN2 and the phosphorylation site is somewhere between aa554 to aa1312ATXN2.
That is consistent with yeast PAS kinase-dependent effects on ATXN2 activity observed in the
phenotypic assay (see Figure 4-3). However, the downstream effect of human PAS kinase on
ATXN2 is not known in mammalian cells, but it may be involved in neural degeneration in
ATXN2 associated ataxias through the inhibition of TORC1.
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_

hPASK
∆ATXN2 ∆ATXN2 ∆ATXN2 _
hPASK

hPASK

hPASK

hPASK

GAPDH

GAPDH

32P

CB

Figure 4-4: Evidence for in vitro phosphorylation of ∆N554ATXN2 by hPASK. ∆N554ATXN2
was expressed and purified from psk1psk2 yeast cells and then assayed for in vitro
phosphorylation by hPASK in the presence of 32P ATP. Phosphorylation of ∆N554ATXN2 was
verified by assessing hPASK auto-phosphorylation in the absence of ATXN2, and in the
presence of non hPASK substrate GAPDH. Kinase reactions were visualized on 10% SDS–
PAGE gels, stained with Coomassie brilliant blue (CB), and exposed on x-ray film.
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4.3

Evidence of in vivo interaction between Pbp1/ATXN2 and Psk2
Above we provided evidence for the Psk1-dependent phosphorylation of Pbp1 and ATXN2

in yeast. Psk1 and Psk2 are two partially redundant PASK homologs in yeast [17], and the
effects of Psk2 on Pbp1/ATXN2 have not been assessed. Both Psk1 and Psk2 act as nutrient
sensing kinases and share similar functions in the regulation of glucose homeostasis in the cell,
including the ability to phosphorylate the well-characterized substrate Ugp1 [11]. To determine
whether Psk2 can also phosphorylate Pbp1/ATXN2, the TORC1-dependent caffeine sensitivity
was assessed in psk1 (JGY2) and psk2 (JGY3) yeast cells. In the presence of Psk2,
overexpression of Pbp1 or ATXN2 in yeast cells induced caffeine sensitivity (Figure 4-5) when
compared with the psk1psk2 yeast (Figure 4-3). These results are consistent with Psk2 acting in a
similar manner as Psk1 to inhibit TORC1 activity by phosphorylating either Pbp1 or ATXN2
[22].
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Figure 4-5: Evidence of PSK2 deficiency ameliorates caffeine toxicity due to Pbp1 or
∆N554ATXN2 overexpression. psk1 yeast (JGY2) or psk2 yeast (JGY3) was transformed with
an empty vector (EV, pJG859), a plasmid overexpressing Pbp1 (pJG925) or a plasmid
overexpressing truncated ATXN2 (pJG1360) grown in SD-Ura, serially diluted 1:10, and
spotted on SGal-Ura + 1.87 mM caffeine plates, as well as on a control SD-Ura plate. Plates
were incubated at 30°C for 7–10 d until colonies were apparent.
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4.4

Evidence for direct phosphorylation of Pbp1 by Psk2
The in vivo effects of Psk2 on Pbp1 activity prompted us to investigate whether

∆N419Pbp1 could be phosphorylated by Psk2. His-HA tagged Psk1, Psk2 and kinase-dead Psk2
(K870R) [49] were purified and subjected to in vitro kinase assays with purified Pbp1. PAS
kinase is known to autophosphorylate in vitro [11], making the kinase-dead mutant vital to
ensure Psk2 dependent phosphorylation of Pbp1. Psk2-dependent Pbp1 phosphorylation was
observed in these in vitro assays (Figure 4-6), providing evidence for the direct phosphorylation
of ∆N419Pbp1 by Psk2.

Pbp1

Ugp1

Psk1 Psk2 Psk2-KD Psk1

Psk2

32P

CB

Figure 4-6: Evidence for in vitro phosphorylation of Pbp1 by Psk2. ∆N419Pbp1 was expressed
and purified from psk1psk2 yeast cells and then assayed for in vitro phosphorylation by Psk2 in
the presence of 32P ATP. Pbp1 was verified as Psk2 substrate using a kinase-dead mutant (Psk2K870R). Kinase reactions were visualized on 10% SDS–PAGE gels, stained with Coomassie
brilliant blue (CB), and exposed on X-ray film.
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4.5

Characterization of PAS kinase-dependent phosphorylation of Pbp1 through
phosphosite mapping and mutagenesis.
From the previous data we know that PAS kinase phosphorylates Pbp1 at a threonine

residue and the phosphorylation site is most likely between aa420 to aa722 [52]. Also, PAS
kinase recognizes the consensus phosphorylation motif ([R/K/H]X[R/K/H][S/T/C/P/N/Q]X[T])
[56]. Based on mass spectrometry and in vivo kinase assay [52] data with Pbp1 phosphosite
mutants (single amino acid change) (data not shown) we suspect that phosphorylation occurs at
multiple sites. On the basis of these knowledge we introduced three sets of site-directed mutation
in Pbp1 (Table 3-1) using the StrategeneQuikChange kit. All three sets of Pbp1 mutants were
introduced to in vivo kinase assay (3.6 In vivo kinase assay) by western blot. Unfortunately,
Psk1 is able to phosphorylates all the mutants, making is difficult to identify the critical
phosphorylation site of Pbp1. Thus, more than one site may be the phosphorylated (as has been
shown for other kinase mutants), or we have not identified the correct site. Future work will be
aimed at testing a triple mutant of Pbp1 (to test all three sites at once), and testing truncations of
Pbp1 in the in vitro kinase assay and yeast two-hybrid, to try to narrow in on the critical region.
4.6

Defining the function of Pbp1 through identification of the binding partners
Human ATXN2 plays a pivotal role in the development of human ataxias [39], yet little is

known about its function. As mentioned above, both Pbp1 and its human homologue contain
conserved functional domains (Figure 1-1), are components of glucose stress granules, and are
involved in the regulation of TORC1 (Figure 2-1). In an effort to further elucidate the function
of these proteins, the yeast two-hybrid (Y2H) approach was employed. Pbp1 was cloned into
Bait (pJG1386) and was used to perform large-scale Y2H screens to identify Pbp1 binding
partners. Y2H screens were conducted with two yeast genomic libraries (pJG428, and pJG429)
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[57] and two cDNA libraries (JGY1098 and JGY1074) [49]. From ∼10 million transformants or
mated yeast screened, seven Pbp1 binding partners were identified (Table 4-1). Advantages of

the Y2H approach include the identification of direct protein–protein interactions and sensitivity
due to transcriptional amplification of an interaction [49]. However, the yeast two-hybrid can
also yield false positives that allow growth independent of the bait. To minimize false positives,
the Y2HGold strain was used, which harbors four different reporters control (Clontech
Matchmaker Gold Yeast Two-hybrid System) [57], and each of these binding partners was
verified by purifying the prey plasmid from yeast and retransforming into naive Y2HGold along
with the ΔN419Pbp1 bait or an empty bait plasmid. The strength of growth is an indication of the
interaction strength (Figure 4-7).
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Table 4-1: Pbp1 binding partners identified by the yeast two-hybrid
Gene

Human
Homolog

Gene name
description

Locali
zation

Number
of hits

Pray
library
used

Construct
(Total
number of
aa)

Growth
strength

RNA Processing
MUM2

ERC2

mRNA
methylation

N/C

3

cDNA

aa170 to
aa298
(aa366)
aa2 to
aa192
(aa796)

W

PAT1

SLC36A1

N/C

1

Gen

PKH1

Pdpk1

C/V

1

Hypotheti
cal Protein
(SGDID:S
00000348
2)

-

Deadenylationdependent
mRNAdecapping
factor
Cytoplasmic
mRNA
processing body
assembly
Putative RNA
binding protein,
localizes to
stress granules
induced by
glucose
deprivation

cDNA

aa649 to
aa741
(aa766)

M

C/SG

2

Gen

aa509 to
aa718
(aa718)

W

2

Gen

S

Other Functions
YEN1

GEN1

Response to
DNA damage
stimulus
mitochondrion
degradation,
macroautophagy
misfolded
protein transport

N/C

aa504 to
W
aa759
(aa759)
PTC6
PPM1K
M
1
Gen
aa1 to
S
aa120
(aa442)
SEC61
SEC61A2
ER/M
1
Gen
aa407 to
M
EM
aa480
(aa480)
C corresponds to cytoplasm, MEM to membrane, M to mitochondrion, N to nucleus, ER to
endoplasmic reticulum, V to vacuole and SG to stress granule. S, strong; M, medium; W, weak
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b.

a.

SD-Leu-Trp-His-Ade

Figure 4-7: Dependency assay and Growth comparison. For verification and elimination of false
positives, library plasmids were purified and transformed into Clontech Matchmaker Gold yeast
with either the bait plasmid (pJG1386) or the empty bait plasmid (pJG424). Colonies arising on
the SD-Leu-Trp transformation plates were then streaked to SD-Leu-Trp-His-Ade in duplicate
and allow growing for 3–5 d to test for Pbp1 dependence. The strength of growth was
determined by comparing growth of yeast on SD-Leu-Trp-His-Ade plates, which is an indication
of the interaction strength. (a) SEC61: Medium growth; Hypothetical Protein: Weak growth. (b)
PAT1 and PTC6: Strong Growth.
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5

DISCUSSION

The results of these experiments contribute to our understanding of basic cellular processes
and the regulation of an important metabolic enzyme PAS kinase. Our studies here demonstrate a
crucial regulation of TORC1, a key protein in the regulation of cell growth and proliferation, by
PAS kinase via ATXN2 and Pbp1. The interaction between Pbp1 and PAS kinase 1 (Psk1) in
yeast was demonstrated by DeMille et.al. [57]. This study further characterized the
phosphorylation of Pbp1 by PAS kinase, explored the conservation of the Pbp1/PAS
kinase/TORC1 pathway, and further explored the function of Pbp1 through the identification of
novel binding partners.
There are two homologs of PAS kinase in yeast, Psk1 and Psk2. This is of interest since
proteins that arise from gene duplication often evolve related but differential function. For
example, there are two TOR complexes in eukaryotic cells, TORC1, which primarily regulates
cell growth and proliferation in yeast and mammalian cells, and TOR complex 2 (TORC2),
which primarily regulates the actin cytoskeleton. Although a single protein works in both
complexes in most eukaryotic cells, yeast has two TOR proteins, TOR1 and TOR2, which
function in TORC1 and TORC2 respectively. We, therefore, hypothesized that Psk1 and Psk2
may have differential roles and explored the role of Psk2 in Pbp1 regulation. Phenotypic assays
suggest that Psk2 ameliorates caffeine toxicity due to Pbp1 or ATXN2 overexpression similar to
its homolog Psk1 (Figure 4-5). This study also provided evidence of in vitro phosphorylation of
Pbp1 by Psk2 (Figure 4-6). So far we have not been able to identify the critical phosphorylation
site of Pbp1 activation. The difficulty in mapping critical phosphorylation sites can be explained
by the large size of the protein. However, the ability of Psk1 to phosphorylate the phosphosite
mutants of Pbp1 would suggest that there are multiple phosphorylation sites. It is expected that
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the phosphosite mapping of shorter fragments of Pbp1, as well as combinatorial mutations, by in
vivo kinase assays will allow for a more specific Psk1 phosphorylation site.
In addition to further characterizing the role of yeast PAS kinase in the regulation of Pbp1,
this study provided evidence for the conservation of the PAS kinase/Pbp1/TORC1 pathway in
yeast. Evidence was provided that the human homolog of Pbp1, ATXN2 can complement its
function in yeast cells (Figure 4-2). Under caffeine induced stress, over expression of ATXN2
inhibits TORC1 and thus inhibits cell growth and proliferation. Caffeine sensitivity can be
rescued in psk1psk2 cells, suggesting that phosphorylation of ATXN2 by PAS kinase activates it
which then inhibits TORC1 (Figure 4-3).
In addition to identifying an interaction between PAS kinase and Pbp1, we have also
identified a possible novel substrate of PAS kinase, ATXN2. Evidence suggests that human
mutations in SCA2, the gene encoding ATXN2, is linked to ataxias [60]. In addition, ATXN2
knockout mice studies have also shown the involvement of ATXN2 in the development of
obesity, insulin resistance, and dyslipidemia [65]. However, the molecular function of ATXN2
has not been understood to date [31]. Our study provides evidence that human PAS kinase can
phosphorylate ATXN2 in vitro (Figure 4-4). This can contribute to understand the molecular
mechanisms of neuronal death reported in Ataxin-2-associated ataxia. In addition, we provided
evidence that PAS kinase phosphorylates and activates ATXN2 in yeast, suggesting PAS kinase
may be a therapeutic target in the treatment of ataxias, a disease with few successful treatment
options.
Despite Pbp1’s clear important in the regulation of cell growth and proliferation, only
four binding proteins have been identified Pab1, Lsm12, Pbp4, and Dhh1 [29]. This study
describes the interactome for Pbp1, identifying 7 novel putative binding partners and expanding
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the role of Pbp1 in yeast, which includes 4 proteins that are involved in RNA processing and 3
proteins with other function. As Pbp1 is known component of stress granule it would be
interesting to study interaction between Pbp1 and Hypothetical Protein (SGDID: S000003482), a
putative RNA binding protein found in stress granules induced by glucose deprivation [66].
Thus, this study not only solidified and further characterized a known role for Pbp1 (localization
to P-body), but also provides new pathways for further exploration.
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APPENDIX A
Table 6-1: Yeast strain used
Strain

Background Genotype

JGY1

W303

JGY2

W303

JGY3

W303

JGY4

W303

JGY299

Y2H Gold
(JGY1031)

Y187
(JGY1073)

S288C

Abbreviation a/α

ade2-1 can1-100 his3-11,15 leu2WT
3112 trp1-1 ura3-1
Psk1::his3 ade2-1 can1-100 his311,15 leu2-3112 trp1-1 ura3-1
psk2::kan-MX4 ade2-1 can1-100
his3-11,15 leu2-3112 trp1-1
ura3-1
psk1::his3 psk2::kan-MX4 ade2-1
can1-100 his3-11,15 leu2-3112
trp1-1 ura3-1
PSK2-TAPtag::kanMX ura3-0
trp1-0 SUC2 mal mel gal2 CUP1
flo1 flo8-1
LYS2::GAL1UAS-GAL1TATAHis3, GAL2UAS-Gal2TATAAde2 URA3::MEL1UASMEL1TATA, AUR1-CMEL1,
ura3-52 his3-200 ade2-101 trp1901 leu2-3, 112 gal4del gal80del
metURA3::GAL1-GAL1-LacZ,
MEL1, ura3-52, his3-200, ade2101, trp1-901, leu2-3, 112,
gal4del, gal80del, met-

a

Reference
or source
David
Stillman
(University
of Utah,
Salt Lake
City, UT)
Grose et
al. (2007)

PSK2psk1

a

PSK1psk2

a

Grose et
al. (2007)

psk1psk2

a

Grose et
al. (2007)

WT

α

Jared
Rutter
(University
of Utah,
Salt Lake
City, UT)

Y2H Gold

a

Clontech

Y187

α

Clontech

JGY1074

pGADT7 Mate and Plate
stationary phase YPAD library in
JGY1073

YPAD library α

DeMille et
al. (2014)

JGY1098

pGADT7 Mate and Plate mid-log
YPAGal library in JGY1073

YPAGal
library

DeMille et
al. (2014)
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α

Table 6-1 Continued

JGY1122

BY4743

JGY1161

S288C

JGY1383

Pbp1::KanMx4
His3-1, leu2-0, lys2-0,ura3-0
psk1::hygro psk2::NAT ura3-0
trp1-0 SUC2 mal mel gal2 CUP1
flo1 flo8-1
pJG1386 Pbp1 in Y2H bait
ura3-52, his3-200, ade2-101,
trp1-901,leu2-3,112, gal4del
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pbp1

α

Janet Shaw
(University
of Utah,
Salt Lake
City, UT)

psk1psk2

α

DeMille et
al. (2015)

PBP1-Y2H
Gold

a

This study

Table 6-2: Plasmids used in this study
Plasmid

Gene

Description

Backbone

pJG9
pJG173

PSK1
PSK2

pRS424
pJR1765B

pJG174

PSK2

pJR1765B

pJG421

EV

pJG424

EV

Psk1 in pRS424
Psk2 in pJR1765B
Psk2 K870R kinase dead
mutant
pGAD-C1 empty Y2H prey
vector
pGBD-C1 empty Y2H bait
vector

Yeast
origin
2u
2u

Trp
Ura

Reference or
source
Jared Rutter
Jared Rutter

2u

Ura

Jared Rutter

YEp-GAD 2u

Leu

YEp-GBD 2u

Trp

pGAD-C2 genomic library

YEp-GAD 2u

LEU

Library

pGAD-C3 genomic library

YEp-GAD 2u

LEU

pJG598

PSK1

ΔN692Psk1 in pJG425

YEp-GBD 2u

Trp

pJG725

EV

pADH-Myc

pRS416

CEN

Ura

pJG734

PBP1

ADH ∆N420Pbp1-Myc

pRS416

CEN

Ura

pJG858

PSK1

pGAL1-10, Psk1-HIS/HA

pRS426

2u

Ura

pJG859

EV

pGAL1-10, HIS/HA

pRS426

2u

Ura

pJG925

PBP1

Full-length Pbp1 in pJG859

pRS426

2u

Ura

pJG1250

PBP1

pRS426

2u

Ura

pJG1251

PBP1

pRS426

2u

Ura

pJG1271

PSK1

pRS426

2u

Ura

pJG1331

ATXN2

Full length ATXN2

pGEM-T

2u

Ura

pJG1359
pJG1360
pJG1361
pJG1386
pJG1409

ATXN2
ATXN2
ATXN2
PBP1
PBP1

pRS426
pRS426
pRS426
pRS416
pRS416

2u
2u
2u
CEN
CEN

Ura
Ura
Ura
Ura
Ura

pJG1542

PBP1

∆N379 ATXN2 in pJG859
∆N554 ATXN2 in pJG859
∆N700 ATXN2 in pJG859
∆N419Pbp1 in pJG424
Full length Pbp1 in pJG725
Pbp1 with mutations:
S106A, T193A, S436A,
S479A,T708A,T718A made
with pJG1251

James et al.
(1996)
James et al.
(1996)
James et al.
(1996)
James et al.
(1996)
DeMille et
al. (2014)
David
Stillman
David
Stillman
DeMille et
al. (2014)
DeMille et
al. (2014)
DeMille et
al. (2015)
DeMille et
al. (2015)
DeMille et
al. (2015)
DeMille et
al. (2014)
Sino
Biological
Inc.
This Study
This Study
This Study
This Study
This Study

pJG428

Library

pJG429

pRS416

CEN

Ura

This Study

pGAL1-10, ∆N419Pbp1Myc
pGAL1-10, Full length
Pbp1-Myc
Psk1-D1230A kinase dead
mutant
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Selection

Table 6-2 Continued
pJG1523

PBP1

pJG1544

PBP1

pJG1546

PAT1

pJG1548

Pbp1 with mutations:
S106A, T193A, T355A,
S436A, S479A,T708A
made with pJG1251
Pbp1 with mutations:
S106A, T215A, T355A,
S436A,
S479A,T708A,T718A made
with pJG1251

pRS416

CEN

Ura

This Study

pRS416

CEN

Ura

This Study

PTA1 in Y2H bait

Leu

Hypoth
etical
gene

DeMille et
al. (2014)

Hypothetical gene in Y2H
bait

Leu

DeMille et
al. (2014)

pJG1549

YEN1

YEN1 in Y2H bait

Leu

pJG1560

PBP1

pJG1561

PBP1

pJG1562

PBP1

pJG1563

PBP1

Full length Pbp1 in pJG859
Pbp1 with mutations:
S106A, T193A, S436A,
S479A,T708A,T718A made
with pJG12560
Pbp1 with mutations:
S106A, T193A, T355A,
S436A, S479A,T708A
made with pJG1560
Pbp1 with mutations:
S106A, T215A, T355A,
S436A,
S479A,T708A,T718A made
with pJG1560

pJG1572

SEC61

SEC61 in Y2H bait

Leu

pJG1573

PTC6

PTC6 in Y2H bait

Leu

pJG1574

MUM2

Mum2 in Y2H bait

Leu

pJG1575

PKH1

PKH1 in Y2H bait

Leu
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pRS426

2u

Ura

DeMille et
al. (2014)
This Study

pRS426

2u

Ura

This Study

pRS426

2u

Ura

This Study

pRS426

2u

Ura

This Study
DeMille et
al. (2014)
DeMille et
al. (2014)
DeMille et
al. (2014)
DeMille et
al. (2014)

Table 6-3: Primers used in this study
Primer

Sequence

JG2335
JG2761
JG2762
JG2916
JG2917
JG2953
JG2954
JG2993
JG3037
JG3136
JG3384
JG3704
JG3758
JG3759
JG3760
JG3761
JG3854

TTCGATGATGAAGATACC
CTATTCGATGATGAAGATACCCCACC
AGATGGTGCACGATGCACAG
GCCTCGAGGTTTATGGCCACTGGTACTACTATTATGG
GGCGAATTCATGAAGGGAAACTTTAGGAAAAGAG
GAAGGAAGGAAAGCTCAATTGGGAG
GATTGAAATACTGATTACTTAAAATTTGC
CGCCAGGGTTTTCCCAGTC
CAACCATAGGATGATAATGCGATTAG
GGCGAATTCTCGTTGCCTCCAAAACCGATCAGC
GGCGAATTCATGTCGTTGCCTCCAAAACCGATCAGC
GGCGTCGACTTACAACTGCTGTTGGTGGTGGGC
GGCCAATTGATGCGCTCAGCGGCCGC
GGCCAATTGATGACCCCCAGTGGGCCAGTTCTTG
GGCCAATTGATGTCGCCTTGCCCATCTCCTTCC
GGCCAATTGATGCTCACAGCCAATGAGGAACTTGAG
GGCGTCGACGCAACTGCTGTTGGTGGTGGGC

44

